Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study

MLA

Hui, Qin, et al. “Safety and Efficacy of Secukinumab in Psoriasis Patients Infected with Hepatitis B Virus: A Retrospective Study.” European Journal of Dermatology : EJD, vol. 32, no. 3, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c9ecf316f3035e8490ddbcda06173f36&authtype=sso&custid=ns315887.

APA

Hui, Q., Na, L., Yifan, H., Ning, Y., Xuemei, Y., Yunlu, G., Fujuan, C., Jun, G., Yangfeng, D., & Yuling, S. (2022). Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study. European Journal of Dermatology : EJD, 32(3).

Chicago

Hui, Qin, Liu Na, Hu Yifan, Yu Ning, Yi Xuemei, Gao Yunlu, Chen Fujuan, Gu Jun, Ding Yangfeng, and Shi Yuling. 2022. “Safety and Efficacy of Secukinumab in Psoriasis Patients Infected with Hepatitis B Virus: A Retrospective Study.” European Journal of Dermatology : EJD 32 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c9ecf316f3035e8490ddbcda06173f36&authtype=sso&custid=ns315887.